E. Gelfand, Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases, New England Journal of Medicine, vol.367, issue.21, pp.2015-2025, 2012.
DOI : 10.1056/NEJMra1009433

E. Ephrem, Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis, Blood, vol.111, issue.2, pp.715-722, 2008.
DOI : 10.1182/blood-2007-03-079947

A. Tjon, Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells, Clinical & Experimental Immunology, vol.112, issue.1 Suppl. 57, pp.259-267, 2013.
DOI : 10.1182/blood-2008-02-138073

Y. Hirabayashi, Lack of CD4+CD25+FOXP3+ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease, European Journal of Pediatrics, vol.29, issue.Suppl 1, pp.833-837, 2013.
DOI : 10.1016/j.it.2008.08.004

J. Trinath, Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells, Blood, vol.122, issue.8, pp.1419-1427, 2013.
DOI : 10.1182/blood-2012-11-468264

M. S. Maddur, Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy, Journal of Neuroinflammation, vol.13, issue.1, 2017.
DOI : 10.1186/s12974-016-0628-1
URL : https://hal.archives-ouvertes.fr/hal-01502272

A. H. Massoud, Dendritic cell immunoreceptor: A??novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells, Journal of Allergy and Clinical Immunology, vol.133, issue.3, pp.853-863, 2014.
DOI : 10.1016/j.jaci.2013.09.029

B. M. Fiebiger, Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs, Proceedings of the National Academy of Sciences, vol.14, issue.10, pp.2385-2394, 2015.
DOI : 10.1038/nprot.2006.285
URL : http://www.pnas.org/content/112/18/E2385.full.pdf

D. Groot and A. S. , Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes", Blood, vol.112, issue.8, pp.3303-3311, 2008.
DOI : 10.1182/blood-2008-02-138073

J. Genre, Reduced frequency of CD4+CD25HIGHFOXP3+ cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: A link to autoimmunity?, Clinical Immunology, vol.132, issue.2, pp.215-221, 2009.
DOI : 10.1016/j.clim.2009.03.519

K. Kasztalska, Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease, Clinical Drug Investigation, vol.44, issue.6, pp.299-307, 2011.
DOI : 10.1046/j.1365-3083.1996.d01-350.x